Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
10.1016/j.lfs.2010.12.019 74 PangC.ShengY
At Austin Medicine, weve seen firsthand how the right therapies can restore hope and transform lives
Plessas et al., 2016
A Phase 2 trial found IGF-1 levels plateaued at month 6 despite continued daily dosing, suggesting partial desensitization of the GH-IGF-1 axis under constant stimulation
Helsinn Healthcare conducted clinical development for postoperative GI motility (ipamorelin was investigated as a GI prokinetic given its partial GI tract action through peripheral GHSR-1a), but no NDA was filed
US$ 20.24
US$ 25.42
US$ 27.64
US$ 28.22
